Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pomalidomide

EU orphan designation number: EU/3/12/986   
Active ingredient: Pomalidomide
Indication: Treatment of systemic sclerosis
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Centralised Orphan - Designation EMA/OD/163/11 (2012)2982 of 26/04/2012